Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease.
Clin Exp Rheumatol
; 41(5): 1202-1203, 2023 05.
Article
in English
| MEDLINE | ID: covidwho-2255510
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Pre-Exposure Prophylaxis
/
COVID-19
Topics:
Vaccines
/
Variants
Limits:
Humans
Language:
English
Journal:
Clin Exp Rheumatol
Year:
2023
Document Type:
Article
Affiliation country:
Clinexprheumatol
Similar
MEDLINE
...
LILACS
LIS